These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 20416424)

  • 41. One-visit apexification: technique for inducing root-end barrier formation in apical closures.
    Witherspoon DE; Ham K
    Pract Proced Aesthet Dent; 2001 Aug; 13(6):455-60; quiz 462. PubMed ID: 11544818
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mineral trioxide aggregate: a comprehensive literature review--Part III: Clinical applications, drawbacks, and mechanism of action.
    Parirokh M; Torabinejad M
    J Endod; 2010 Mar; 36(3):400-13. PubMed ID: 20171353
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Orthograde root filling of an immature nonvital tooth using MTA.
    Mohammadi Z
    Dent Today; 2008 Jul; 27(7):102, 104-5. PubMed ID: 18686667
    [No Abstract]   [Full Text] [Related]  

  • 44. Apical plug technique using mineral trioxide aggregate: results from a case series.
    Pace R; Giuliani V; Pini Prato L; Baccetti T; Pagavino G
    Int Endod J; 2007 Jun; 40(6):478-84. PubMed ID: 17403040
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical applications of mineral trioxide aggregate.
    Torabinejad M
    Alpha Omegan; 2004 Dec; 97(4):23-31. PubMed ID: 15651581
    [No Abstract]   [Full Text] [Related]  

  • 46. Periapical tissue reactions to calcium hydroxide and MTA after external root resorption as a sequela of delayed tooth replantation.
    Marão HF; Panzarini SR; Aranega AM; Sonoda CK; Poi WR; Esteves JC; Silva PI
    Dent Traumatol; 2012 Aug; 28(4):306-13. PubMed ID: 22151580
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pulpal response to nano hydroxyapatite, mineral trioxide aggregate and calcium hydroxide when used as a direct pulp capping agent: an in vivo study.
    Swarup SJ; Rao A; Boaz K; Srikant N; Shenoy R
    J Clin Pediatr Dent; 2014; 38(3):201-6. PubMed ID: 25095313
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vital pulp therapy with new materials for primary teeth: new directions and Treatment perspectives.
    Fuks AB
    Pediatr Dent; 2008; 30(3):211-9. PubMed ID: 18615986
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Vital pulp therapy with new materials for primary teeth: new directions and treatment perspectives.
    Fuks AB
    J Endod; 2008 Jul; 34(7 Suppl):S18-24. PubMed ID: 18565366
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of the formocresol versus mineral trioxide aggregate primary molar pulpotomy: a meta-analysis.
    Peng L; Ye L; Tan H; Zhou X
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Dec; 102(6):e40-4. PubMed ID: 17138165
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pulp capping with mineral trioxide aggregate (MTA): a retrospective analysis of carious pulp exposures treated by undergraduate dental students.
    Miles JP; Gluskin AH; Chambers D; Peters OA
    Oper Dent; 2010; 35(1):20-8. PubMed ID: 20166407
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Management of a talon cusp using mineral trioxide aggregate.
    Shetty P; Xavier AM
    Int Endod J; 2011 Nov; 44(11):1061-8. PubMed ID: 21718335
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Human pulpal response to mineral trioxide aggregate (MTA): a histologic study.
    Chacko V; Kurikose S
    J Clin Pediatr Dent; 2006; 30(3):203-9. PubMed ID: 16683667
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Repair of furcal perforation with mineral trioxide aggregate: long-term follow-up of 2 cases.
    Silveira CM; Sánchez-Ayala A; Lagravère MO; Pilatti GL; Gomes OM
    J Can Dent Assoc; 2008 Oct; 74(8):729-33. PubMed ID: 18845064
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dentin bridge formation after mineral trioxide aggregate (MTA) pulpotomies in primary teeth.
    Maroto M; Barbería E; Planells P; García Godoy F
    Am J Dent; 2005 Jun; 18(3):151-4. PubMed ID: 16158803
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of mineral trioxide aggregate and formocresol as pulp-capping agents in pulpotomized primary teeth.
    Agamy HA; Bakry NS; Mounir MM; Avery DR
    Pediatr Dent; 2004; 26(4):302-9. PubMed ID: 15344622
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of CaOH with MTA for direct pulp capping: a PBRN randomized clinical trial.
    Hilton TJ; Ferracane JL; Mancl L;
    J Dent Res; 2013 Jul; 92(7 Suppl):16S-22S. PubMed ID: 23690353
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treatment outcome after repair of root perforations with mineral trioxide aggregate: a retrospective evaluation of 90 teeth.
    Krupp C; Bargholz C; Brüsehaber M; Hülsmann M
    J Endod; 2013 Nov; 39(11):1364-8. PubMed ID: 24139255
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fracture resistance of immature teeth filled with BioAggregate, mineral trioxide aggregate and calcium hydroxide.
    Tuna EB; Dinçol ME; Gençay K; Aktören O
    Dent Traumatol; 2011 Jun; 27(3):174-8. PubMed ID: 21504540
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical, radiographic and histological analysis of the effects of mineral trioxide aggregate used in direct pulp capping and pulpotomies of primary teeth.
    Caicedo R; Abbott PV; Alongi DJ; Alarcon MY
    Aust Dent J; 2006 Dec; 51(4):297-305. PubMed ID: 17256303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.